# Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome

> **NCT04117802** · NA · COMPLETED · sponsor: **Laval University** · enrollment: 47 (actual)

## Conditions studied

- Overweight
- Microbiota
- Endotoxemia
- Metabolic Syndrome
- Non-Alcoholic Fatty Liver Disease
- Insulin Resistance

## Interventions

- **OTHER:** Maple syrup
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04117802
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-03
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04117802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04117802, "Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04117802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*